CBD Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.33	0.01	0	0	1.03
Cash & Short-Term Investments	0.33	0.01	0	0	1.03
Cash Growth	4963.34%	160.29%	350.90%	-99.95%	25862.97%
Other Receivables	0.22	0.2	-	-	-
Receivables	0.22	0.2	-	-	-
Inventory	0.04	0.03	0.02	0.01	0.05
Total Current Assets	0.58	0.24	0.02	0.01	1.07
Property, Plant & Equipment	-	0.03	0.09	0.16	0.19
Long-Term Investments	0.1	-	-	-	-
Goodwill	0.1	0.1	0.1	0.1	0.1
Other Intangible Assets	-	0.01	0.03	0.03	-
Other Long-Term Assets	0	0	0	0	0
Total Assets	0.79	0.39	0.24	0.3	1.36
Accounts Payable	0.03	-	-	-	-
Accrued Expenses	0.01	0.01	0.02	-	-
Other Current Liabilities	-	-	0.18	0.17	-
Total Current Liabilities	0.04	0.01	0.2	0.17	-
Other Long-Term Liabilities	-	-	-	-	0.03
Total Liabilities	0.04	0.01	0.2	0.17	0.03
Common Stock	4.65	4.37	4.07	4.07	4.07
Additional Paid-In Capital	11.42	11.28	10.48	10.48	10.82
Retained Earnings	-15.37	-15.32	-14.56	-14.48	-13.62
Comprehensive Income & Other	-0.02	-0.02	-0.01	-	-
Total Common Equity	0.68	0.31	-0.02	0.07	1.27
Shareholders' Equity	0.75	0.37	0.04	0.13	1.33
Total Liabilities & Equity	0.79	0.39	0.24	0.3	1.36
Net Cash (Debt)	0.33	0.01	0	0	1.03
Net Cash Growth	4963.34%	160.29%	350.90%	-99.95%	25862.97%
Net Cash Per Share	0.00	0.00	0.00	-	0.01
Filing Date Shares Outstanding	5,932	641.7	141.69	135.69	135.69
Total Common Shares Outstanding	5,932	641.7	141.69	135.69	135.69
Working Capital	0.54	0.23	-0.18	-0.16	1.07
Book Value Per Share	0.00	0.00	-0.00	0.00	0.01
Tangible Book Value	0.58	0.2	-0.15	-0.06	1.17
Tangible Book Value Per Share	0.00	0.00	-0.00	-0.00	0.01
Machinery	-	-	-	-	0.01
Leasehold Improvements	-	-	-	-	0.15